Merck KGaA
MKKGY
$25.60
-$0.7299-2.77%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.96B | 5.56B | 5.78B | 5.79B | 5.76B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.96B | 5.56B | 5.78B | 5.79B | 5.76B |
| Cost of Revenue | 2.53B | 2.25B | 2.43B | 2.33B | 2.28B |
| Gross Profit | 3.44B | 3.31B | 3.35B | 3.46B | 3.48B |
| SG&A Expenses | 1.68B | 1.54B | 1.69B | 1.55B | 1.60B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 137.33M | 126.28M | -244.11M | 124.23M | 334.74M |
| Total Operating Expenses | 4.95B | 4.50B | 4.43B | 4.58B | 4.91B |
| Operating Income | 1.01B | 1.06B | 1.35B | 1.21B | 853.53M |
| Income Before Tax | 940.86M | 1.01B | 863.43M | 1.15B | 844.92M |
| Income Tax Expenses | 197.48M | 229.41M | 149.24M | 253.96M | 193.74M |
| Earnings from Continuing Operations | 743.38M | 776.63M | 714.20M | 892.69M | 651.18M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.40M | -3.16M | -3.20M | -3.30M | 2.15M |
| Net Income | 739.97M | 773.47M | 711.00M | 889.40M | 653.34M |
| EBIT | 1.01B | 1.06B | 1.35B | 1.21B | 853.53M |
| EBITDA | 1.50B | 1.56B | 1.74B | 1.70B | 1.33B |
| EPS Basic | 1.70 | 1.78 | 1.64 | 2.04 | 1.51 |
| Normalized Basic EPS | 1.35 | 1.44 | 2.05 | 1.64 | 1.22 |
| EPS Diluted | 1.70 | 1.78 | 1.64 | 2.04 | 1.51 |
| Normalized Diluted EPS | 1.35 | 1.44 | 2.05 | 1.64 | 1.22 |
| Average Basic Shares Outstanding | 434.67M | 434.91M | 434.80M | 434.95M | 433.57M |
| Average Diluted Shares Outstanding | 434.67M | 434.91M | 434.80M | 434.95M | 433.57M |
| Dividend Per Share | -- | -- | 2.35 | -- | -- |
| Payout Ratio | 152.30% | 6.26% | 0.00% | -- | 161.12% |